USP9X and ovarian carcinoma: Genetic ablation of USP9X markedly reduced GS protein levels in U251 and U343 GBM cell lines as well as in SKOV3, an ovarian cancer cell line (Figure 3I; Figure S4D,E, Supporting Information).